Also Read, Nov. 24 -- Under the agreement, the price of the R21/Matrix-M vaccine will fall to $2.99 per dose within a year - a reduction expected to save up to $90 million. Those savings should allow countries to secure more than 30 million extra doses over the next five years.

Unprecedented tragedy: US records first death linked to H5N5 bird flu

"Today's announcement is a powerful example of what our Vaccine Alliance does best," said An Vermeersch, Gavi's Chief Vaccine Programmes & Markets Officer.

"We are leveraging innovative financing and partnerships to secure affordable vaccines that can better protect children against one of Africa's biggest killers."

Malaria remains one of the world's deadliest infectious diseases. In 2023, it...